You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 5, 2024

List of Excipients in API hydrocortisone acetate


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing hydrocortisone acetate

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
Meda Pharmaceuticals Inc CORTIFOAM hydrocortisone acetate 0037-6830 CETYL ALCOHOL
Meda Pharmaceuticals Inc CORTIFOAM hydrocortisone acetate 0037-6830 ETHYLENE DISTEARAMIDE
Meda Pharmaceuticals Inc CORTIFOAM hydrocortisone acetate 0037-6830 ISOBUTANE
Meda Pharmaceuticals Inc CORTIFOAM hydrocortisone acetate 0037-6830 METHYLPARABEN
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Sign Up

Detailed excipient profiles for hydrocortisone acetate

Excipient focus: BENZYL CHLORIDE

Excipient focus: CARBOMER HOMOPOLYMER TYPE C

Excipient focus: CETYL ALCOHOL

Excipient focus: DIISOPROPYL ADIPATE

Excipient focus: DIMETHICONE

Excipient focus: EDETATE DISODIUM

Excipient focus: ETHYLENE DISTEARAMIDE

Excipient focus: GLYCERIN

Excipient focus: HYDROGENATED COCONUT OIL

Excipient focus: ISOBUTANE

Excipient focus: ISOPROPYL ALCOHOL

Excipient focus: ISOPROPYL MYRISTATE

Excipient focus: ISOPROPYL PALMITATE

Excipient focus: LANOLIN

Excipient focus: METHYLPARABEN

Excipient focus: PETROLATUM

Excipient focus: POLYOXYL 40 STEARATE

hydrocortisone acetate drug variants containing POLYOXYL 40 STEARATE

Company Ingredient NDC
Sebela Pharmaceuticals Inc hydrocortisone acetate and pramoxine hydrochloride 54766-716
Sebela Pharmaceuticals Inc hydrocortisone acetate and pramoxine hydrochloride 54766-726
Sebela Pharmaceuticals Inc hydrocortisone acetate and pramoxine hydrochloride 54766-729
Sebela Pharmaceuticals Inc hydrocortisone acetate and pramoxine hydrochloride 54766-778
>Company >Ingredient >NDC

Subscribe to access the full database, or Sign Up

Excipient focus: POTASSIUM SORBATE

hydrocortisone acetate drug variants containing POTASSIUM SORBATE

Company Ingredient NDC
Sebela Pharmaceuticals Inc hydrocortisone acetate and pramoxine hydrochloride 54766-716
Sebela Pharmaceuticals Inc hydrocortisone acetate and pramoxine hydrochloride 54766-726
Sebela Pharmaceuticals Inc hydrocortisone acetate and pramoxine hydrochloride 54766-729
Sebela Pharmaceuticals Inc hydrocortisone acetate and pramoxine hydrochloride 54766-778
>Company >Ingredient >NDC

Subscribe to access the full database, or Sign Up

Excipient focus: POVIDONE

Excipient focus: PROPANE

Excipient focus: PROPYLENE GLYCOL

Excipient focus: PROPYLPARABEN

Excipient focus: SODIUM METABISULFITE

Excipient focus: SORBIC ACID

hydrocortisone acetate drug variants containing SORBIC ACID

Company Ingredient NDC
Sebela Pharmaceuticals Inc hydrocortisone acetate and pramoxine hydrochloride 54766-716
Sebela Pharmaceuticals Inc hydrocortisone acetate and pramoxine hydrochloride 54766-726
Sebela Pharmaceuticals Inc hydrocortisone acetate and pramoxine hydrochloride 54766-729
Sebela Pharmaceuticals Inc hydrocortisone acetate and pramoxine hydrochloride 54766-778
>Company >Ingredient >NDC

Subscribe to access the full database, or Sign Up

Excipient focus: SORBITAN MONOLAURATE

Excipient focus: SORBITAN SESQUIOLEATE

Excipient focus: STEARETH-10

Excipient focus: STEARIC ACID

Excipient focus: STEARYL ALCOHOL

Excipient focus: TRIETHANOLAMINE LAURYL SULFATE

hydrocortisone acetate drug variants containing TRIETHANOLAMINE LAURYL SULFATE

Company Ingredient NDC
Padagis Israel Pharmaceuticals Ltd hydrocortisone acetate pramoxine hcl 45802-144
Sebela Pharmaceuticals Inc hydrocortisone acetate and pramoxine hydrochloride 54766-716
Sebela Pharmaceuticals Inc hydrocortisone acetate and pramoxine hydrochloride 54766-778
Bryant Ranch Prepack hydrocortisone acetate pramoxine hcl 63629-8669
>Company >Ingredient >NDC

Subscribe to access the full database, or Sign Up

Excipient focus: TROLAMINE

Excipient focus: UREA

Excipient focus: WATER

Excipient focus: XANTHAN GUM

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
 NCE-1 Patent Challenge Dates 2024 - 2025
 Trigger-based marketing for the life sciences
 Get DrugPatentWatch Business Intelligence Reports at Amazon.com
 DrugChatter - AI-based answers to questions about drugs
 RxJam - Digital Marketing for Life Sciences
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links

Follow DrugPatentWatch:

  DrugPatentWatch Linkedin Group